학술논문
CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia
Document Type
Correspondence
Author
Source
In Blood Advances 24 January 2023 7(2):251-255
Subject
Language
ISSN
2473-9529